The case that Ozempic (NVO) and other GLP-1 medications could help people with substance use disorders is getting stronger.

Hunsaker finds an improvement in the “volume and variety” of funding from the UKIB and others since his original report into ...

My grandpa really loves golf,” Staunton senior Lilly Bandy said. “He’s always played, so I decided to try it out. I had never ...

Eli Lilly has thrown its weight behind a cause beyond the traditional remit of pharma companies. | Eli Lilly has thrown its ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Artificial intelligence can revolutionize drug discovery by expediting development, reducing costs, and improving treatment ...

UNICEF is working to strengthen under-resourced health systems around the world to improve outcomes for children and family ...

Over the last couple of years, pharmaceutical giant Eli Lilly (NYSE: LLY) has made a splash in the red-hot weight loss space.

This week’s news from the life sciences includes Eli Lilly's investment in a Cambridge-Singapore biotech, Stealth ...

Unfortunately, many of our elected leaders today undervalue the role of patents to progress the science of drug discovery and ...

The U.S. Food and Drug Administration (FDA) is rethinking its decision to remove popular weight-loss and diabetes drugs from ...

There's no playbook for how to be competitive in artificial intelligence (AI) as a big pharma company, but Eli Lilly (NYSE: LLY) is taking a shot at developing one. With the appointment of a new chief ...